Next Generation Sequencing in Pediatric Epilepsy Using Customized Panels: Size Matters
Introduction Next generation sequencing (NGS) with customized gene panels is a helpful tool to identify monogenic epilepsy syndromes. The number of genes tested within a customized panel may vary greatly. The aim of the present study was to compare the diagnostic yield of small (<25 kb) and large (>25 kb) customized epilepsy panels.
Methods This retrospective cohort study investigated data of 190 patients of 18 years or younger, with the diagnosis of an epilepsy of unknown etiology who underwent NGS using customized gene panels. Small (<25 kb) and large (>25 kb) panels were compared regarding the distribution of benign/likely benign and pathogenic/likely pathogenic variants and variants of unclear significance. In addition, differences of the diagnostic yield with respect to epilepsy severity, i.e., developmental and epileptic encephalopathy [DEE] vs. non-DEE, were analyzed.
Results The diagnostic yield defined as pathogenic or likely pathogenic variants in large panels was significantly increased (29% [n = 14/48] vs. 13% [n = 18/142], p = 0.0198) compared with smaller panels. In non-DEE patients the increase of the diagnostic yield in large panels was significant(35% n = 6/17 vs. 13% n = 12/94, p = 0.0378), which was not true for DEE patients.
Discussion This study indicates that large panels are superior for pediatric patients with epilepsy forms without encephalopathy (non-DEE). For patients suffering from DEE small panels of a maximum of 10 genes seem to be sufficient. The proportion of unclear findings increases with rising panel sizes.
Conclusion Customized epilepsy panels of >25 kb compared with smaller panels show a significant higher diagnostic yield in patients with epilepsy especially in non-DEE patients.
Keywordsnext generation sequencing - NGS panel - pediatric epilepsy - customized panel - panel size - yield
Received: 09 February 2020
Accepted: 07 April 2020
21 October 2020 (online)
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Chambers C, Jansen LA, Dhamija R. Review of commercially available epilepsy genetic panels. J Genet Couns 2016; 25 (02) 213-217
- 2 Mercimek-Mahmutoglu S, Patel J, Cordeiro D. et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia 2015; 56 (05) 707-716
- 3 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
- 4 Ko A, Youn SE, Kim SH. et al. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy. Epilepsy Res 2018; 141: 48-55
- 5 McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol 2016; 15 (03) 304-316
- 6 Berg AT, Berkovic SF, Brodie MJ. et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51 (04) 676-685
- 7 Stark Z, Schofield D, Alam K. et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med 2017; 19 (08) 867-874
- 8 Hoelz H, Herdl C, Gerstl L. et al. Impact on clinical decision making of next-generation sequencing in pediatric epilepsy in a tertiary epilepsy referral center. Clin EEG Neurosci 2020; 51 (01) 61-69
- 9 Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57 (01) 289-300
- 10 Trump N, McTague A, Brittain H. et al. Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis. J Med Genet 2016; 53 (05) 310-317
- 11 Zhang Q, Li J, Zhao Y, Bao X, Wei L, Wang J. Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy. Clin Genet 2017; 91 (05) 717-724
- 12 Parrini E, Marini C, Mei D. et al; Clinical Study Group. Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum Mutat 2017; 38 (02) 216-225
- 13 Ortega-Moreno L, Giraldez BG, Soto-Insuga V, et al. Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes. PloS one 2017;12(11):e0188978
- 14 Segal E, Pedro H, Valdez-Gonzalez K, et al. Diagnostic yeld of epilepsy panels in children with medication-refractory epilepsy. Pediatr Neurol 2016;64:66–71
- 15 Della Mina E, Ciccone R, Brustia F, et al. Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform. Eur J of Hum Genet 2015;23(3):354–362
- 16 Wang J, Gotway G, Pascual JM, Park JY. Diagnostic yield of clinical next-generation sequencing panels for epilepsy. JAMA Neurol 2014;71(5):650–651
- 17 Lemke JR, Riesch E, Scheurenbrand T. et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012; 53 (08) 1387-1398
- 18 Ream MA, Patel AD. Obtaining genetic testing in pediatric epilepsy. Epilepsia 2015;56(10):1505–1514
- 19 Dunn P, Albury CL, Maksemous N, et al. Next generation sequencing methods for diagnosis of epilepsy syndromes. Front Genet 2018;9:20
- 20 Snoeijen-Schouwenaars FM, van Ool JS, Verhoeven JS. et al. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability. Epilepsia 2019; 60 (01) 155-164
- 21 Heyne HO, Singh T, Stamberger H. et al; EuroEPINOMICS RES Consortium. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet 2018; 50 (07) 1048-1053
- 22 Heyne HO, Artomov M, Battke F. et al. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med 2019; 21 (11) 2496-2503
- 23 Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals. Am J Hum Genet 2019;105(2):267–282